Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex Vivo Sclerotherapy Mechanisms in Varicose Veins
NCT06192472Completed
- Sponsor
- University of Surrey
- Start
- Apr 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of sodium tetradecyl sulfate and 10XB101 in Varicose Veins (4 arms), sponsored by University of Surrey. Primary endpoint: Mechanisms responsible for the therapeutic effects of sclerotherapy in varicose veins. Started Apr 2013; status: completed.
02
Drugs
sodium tetradecyl sulfate10XB101
03
Conditions
Varicose Veins
Beyond the preview
Go deeper on NCT06192472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06192472.